Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?

Ziya KALEM, (Gürgan Clinic Tüp Bebek ve Kadın Sağlığı Merkezi, Ankara, Türkiye)
Aşkı ElLİBEŞ KAYA, (Düzce Üniversitesi, Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, Düzce, Türkiye)
Batuhan BAKIRARAR, (Ankara Üniversitesi, Biyoistatistik Bölümü, Ankara, Türkiye)
Müberra NAMLI KALEM (Bahçeşehir Üniversitesi, Kadın Hastalıkları ve Doğum Bölümü, İstanbul, Türkiye)
Turkish Journal of Obstetrics and Gynecology
0 0
Yıl: 2019 Cilt: 16 Sayı: 1 Sayfa Aralığı: 35 - 40 Metin Dili: İngilizce DOI: 10.4274/tjod.galenos.2019.21384 İndeks Tarihi: 12-10-2020

Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?

Öz:
Objective: To evaluate the relationship between nuchal translucency (NT) values with birthweight and the wellbeing of the newborn.Materials and Methods: This retrospective cohort study that included 508 patients made use of data on healthy full-term, singleton, live birth newborns in a university hospital between 2016 and 2018. The relationship between the NT multiple of the median (MoM) value and maternal body mass index, birthweight, sex, need for neonatal intensive care unit (NICU), and APGAR scores was evaluated. Similarly, the relationship between birthweight and NT MoM, and biochemical data in the first trimester was also evaluated.Results: There was a positive correlation between NT and birthweight (p<0.001). The need for NICU admission increased (p=0.001), and APGAR 1st minute scores decreased (p=0.001) with increasing NT, and APGAR 5th minute scores remained unchanged (p=0.057).Conclusion: The present study identified a positive correlation between first trimester NT and birthweight, and a negative correlation with the wellbeingof the neonate.
Anahtar Kelime:

Fetal ense kalınlığı: Doğum kilosu ve yenidoğan iyilik hali ile bir ilişkisi var mı?

Öz:
Amaç: Yenidoğan iyilik hali ve doğum kilosu ile ense kalınlığı (NT) değerleri arasındaki ilişkiyi değerlendirmekGereç ve Yöntemler: Bu retrospektif kohort çalışma 2016-2018 yılları arasında bir üniversite hastanesinde takipli; sağlıklı, miadında ve tekil yenidoğan ile sonuçlanan 508 gebeliği kapsamaktadır. NT-ortalamanın kat (MoM) değerleri ile maternal vücut kitle indeksi, doğum kilosu, cinsiyet, bebek yoğun bakım (NICU) ihtiyacı ve APGAR skorları değerlendirildi. Benzer şekilde ilk trimesterda da doğum kilosu, NT-MoM ve biyokimyasal data değerlendirildi.Bulgular: NT ve doğum kilosu arasında pozitif korelasyon saptandı (p<0,001). NT değerleri arttıkça APGAR 5. dakika skorları değişmezken (p=0,057); 1. dakika skorlarının düştüğü (p=0,001) ve NICU ihtiyacının arttığı saptandı (p=0,001).Sonuç: Bu çalışmada, birinci trimester NT ile doğum kilosu arasında pozitif korelasyon, yenidoğan iyilik hali ile negative korelasyon saptandı.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Bunduki V, Zugaib M. The Fetus at the First Trimester. In Atlas of Fetal Ultrasound 2018 (pp. 15-28). Springer, Cham.
  • 2. Kagan KO, Wright D, Nicolaides KH. First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol 2015;45:42-7.
  • 3. Burger NB, Bekker MN, Kok E, De Groot CJ, Martin JF, Shou W, et al. Increased nuchal translucency origins from abnormal lymphatic development and is independent of the presence of a cardiac defect. Prenat Diagn 2015;35:1278-86.
  • 4. Taipale P, Hiilesmaa V, Salonen R, Ylöstalo P. Increased nuchal translucency as a marker for fetal chromosomal defects. N Engl J Med 1997;337:1654-8.
  • 5. Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1998;11:391-400.
  • 6. Lithner CU, Kublickas M, Ek S. Pregnancy outcome for fetuses with increased nuchal translucency but normal karyotype. J Med Screen 2016;23:1-6.
  • 7. Äyräs O, Eronen M, Tikkanen M, Rahkola-Soisalo P, Paavonen J, Stefanovic V. Long-term outcome in apparently healthy children with increased nuchal translucency in the first trimester screening. Acta Obstet Gynecol Scand 2016;95:541-6.
  • 8. Lichtenbelt KD, Diemel BD, Koster MP, Manten GT, Siljee J, SchuringBlom GH, et al. Detection of fetal chromosomal anomalies: does nuchal translucency measurement have added value in the era of non-invasive prenatal testing? Prenat Diagn 2015;35:663-8.
  • 9. Maya I, Yacobson S, Kahana S, Yeshaya J, Tenne T, Agmon-Fishman I, et al. Cut-off value of nuchal translucency as indication for chromosomal microarray analysis. Ultrasound Obstet Gynecol 2017;50:332-5.
  • 10. Sharifzadeh M, Adibi A, Kazemi K, Hovsepian S. Normal reference range of fetal nuchal translucency thickness in pregnant women in the first trimester, one center study. J Res Med Sci 2015;20:969.
  • 11. Huang T, Wang F, Boucher K, O’Donnell A, Rashid S, Summers AM. Racial differences in first trimester nuchal translucency. Prenat Diagn 2007;27:1174-6.
  • 12. Chen M, Lam YH, Tang MH, Lee CP, Sin SY, Tang R, et al. The effect of ethnic origin on nuchal translucency at 10-14 weeks of gestation. Prenat Diagn 2002;22:576-8.
  • 13. Salomon LJ, Hourrier S, Fanchin R, Ville Y, Rozenberg P. Is firsttrimester crown-rump length associated with birthweight?. BJOG 2011;118:1223-8.
  • 14. Pardo J, Peled Y, Yogev Y, Melamed N, Ben-Haroush A. Association of Crown-Rump Length at 11 to 14 Weeks’ Gestation and Risk of a Large-for-Gestational-Age Neonate. J Ultrasound Med 2010;29:1315- 9.
  • 15. Pardo J, Peled Y, Yogev Y, Melamed N, Ben-Haroush A. Association of Crown-rump Length at 11 to 14 Weeks’ Gestation and Risk of a Large-for-gestational-age Neonate. J Ultrasound Med 2011;66:10-1.
  • 16. Smith GC, Smith MF, McNay MB, Fleming JE. First-trimester growth and the risk of low birth weight. N Engl J Med 1998;339:1817-22.
  • 17. Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, et al. Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 2004;191:1452-8.
  • 18. Kelekci S, Yilmaz B, Savan K, Sonmez S. Can increased nuchal translucency in the first trimester of pregnancy predict gestational diabetes mellitus. J Obstet Gynaecol 2005;25:579-82.
  • 19. Weissmann-Brenner A, Weisz B, Lerner-Geva L, Gindes L, Achiron R. Increased nuchal translucency is associated with large for gestational age neonates in singleton pregnancies. J Perinat Med 2011;39:305-9.
  • 20. Hackmon R, Librach C, Burwick R, Rodrigues N, Farine D, Berger H. Do Early Fetal Measurements and Nuchal Translucency Correlate With Term Birth Weight?. J Obstet Gynaecol Can 2017;399:750-6.
  • 21. Namlı Kalem M, Kalem Z, Bakırarar B, Ergün A, Gürgan T. The effect of progesterone use in the first trimester on fetal nuchal translucency. J Turk Ger Gynecol Assoc 2018;19: 29.
  • 22. Giorlandino C, Cignini P, Padula F, Giannarelli D, d’Emidio L, Aloisi A, et al. Effects of exogenous progesterone on fetal nuchal translucency: an observational prospective study. Am J Obstet Gynecol 2015;212:335-e1.
  • 23. Griesinger G, Meldrum D. Introduction: Management of the luteal phase in assisted reproductive technology. Fertil Steril 2018;109:747- 8.
  • 24. Child T, Leonard SA, Evans JS, Lass A. Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles. Reprod Biomed Online 2018;36:630-45.
  • 25. Plasencia W, González Dávila E, Tetilla V, Padrón Pérez E, García Hernández JA, & González Maternal NL. First-trimester screening for large-for-gestational-age infants. Ultrasound Obstet Gynecol 2012;39:389-95.
  • 26. Spencer K, Ong CY, Liao AW, Papademetriou D, Nicolaides KH. The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 2000;20:673-5.
  • 27. Weissmann-Brenner A, Weisz B, Lerner-Geva L, Gindes L, Achiron R. Increased nuchal translucency is associated with large for gestational age neonates in singleton pregnancies. J Perinat Med 2011;39:305-9.
  • 28. Siega-Riz AM, Viswanathan M, Moos MK, Deierlein A, Mumford S, Knaack J, et al. A systematic review of outcomes of maternal weight gain according to the Institute of Medicine recommendations: birthweight, fetal growth, and postpartum weight retention. Am J Obstet Gynecol 2009;201:339-e1.
  • 29. Kalem MN, Kamalak Z, Kosus N, Kosus A, Kalem Z. Prenatal multivitamin supplementation increases birth weight. Int J Reprod Contracept Obstet and Gynecol 2017;6:2148-53.
  • 30. Ko TJ, Tsai LY, Chu LC, Yeh SJ, Leung C, Chen CY, et al. Parental smoking during pregnancy and its association with low birth weight, small for gestational age, and preterm birth offspring: a birth cohort study. Pediatr Neonatol 2014;55:20-7.
  • 31. Bakker M, Pajkrt E, Bilardo CM. Increased nuchal translucency with normal karyotype and anomaly scan: What next?. Best Pract Res Clin Obstet Gynaecol 2014;28:355-66.
  • 32. Äyräs O, Eronen M, Tikkanen M, Rahkola-Soisalo P, Paavonen J, Stefanovic V Long-term neurodevelopmental outcome of children from euploid pregnancies with increased nuchal translucency in the first trimester screening. Prenat Diagn 2015;35:362-9.
  • 33. Thorngren-Jerneck K, HerbstA. Low 5-minute Apgar score: a population-based register study of 1 million term births. Obstet Gynecol 2001;98:65-70.
  • 34. Rüdiger M, Braun N, Aranda J, Aguar M, Bergert R, Bystricka, et al. (2015). Neonatal assessment in the delivery room-Trial to Evaluate a Specified Type of Apgar (TEST-Apgar). BMC pediatrics 2015;15:18.
  • 35. Lee H, Han S, Lee Y, Kim S. The correlation of nuchal translucency and maternal serum aneuploidy markers with placental dysfunction. Ultrasound in Obstetrics & Gynecology 2017;50:335-335. EP16.13.
  • 36. Yang X, Li R, Fu F, Zhang Y, Li D, Liao C. Submicroscopic chromosomal abnormalities in fetuses with increased nuchal translucency and normal karyotype. J Matern Fetal Neonatal Med 2017;30:194-8.
  • 37. Yang X, Li R, Fu F, Zhang Y, Li D, Liao C. Submicroscopic chromosomal abnormalities in fetuses with increased nuchal translucency and normal karyotype. J Matern Fetal Neonatal Med 2017;30:194-8.
APA KALEM Z, ELLİBEŞ KAYA A, BAKIRARAR B, KALEM M (2019). Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?. , 35 - 40. 10.4274/tjod.galenos.2019.21384
Chicago KALEM Ziya,ELLİBEŞ KAYA AŞKI,BAKIRARAR Batuhan,KALEM Müberra Namlı Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?. (2019): 35 - 40. 10.4274/tjod.galenos.2019.21384
MLA KALEM Ziya,ELLİBEŞ KAYA AŞKI,BAKIRARAR Batuhan,KALEM Müberra Namlı Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?. , 2019, ss.35 - 40. 10.4274/tjod.galenos.2019.21384
AMA KALEM Z,ELLİBEŞ KAYA A,BAKIRARAR B,KALEM M Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?. . 2019; 35 - 40. 10.4274/tjod.galenos.2019.21384
Vancouver KALEM Z,ELLİBEŞ KAYA A,BAKIRARAR B,KALEM M Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?. . 2019; 35 - 40. 10.4274/tjod.galenos.2019.21384
IEEE KALEM Z,ELLİBEŞ KAYA A,BAKIRARAR B,KALEM M "Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?." , ss.35 - 40, 2019. 10.4274/tjod.galenos.2019.21384
ISNAD KALEM, Ziya vd. "Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?". (2019), 35-40. https://doi.org/10.4274/tjod.galenos.2019.21384
APA KALEM Z, ELLİBEŞ KAYA A, BAKIRARAR B, KALEM M (2019). Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?. Turkish Journal of Obstetrics and Gynecology, 16(1), 35 - 40. 10.4274/tjod.galenos.2019.21384
Chicago KALEM Ziya,ELLİBEŞ KAYA AŞKI,BAKIRARAR Batuhan,KALEM Müberra Namlı Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?. Turkish Journal of Obstetrics and Gynecology 16, no.1 (2019): 35 - 40. 10.4274/tjod.galenos.2019.21384
MLA KALEM Ziya,ELLİBEŞ KAYA AŞKI,BAKIRARAR Batuhan,KALEM Müberra Namlı Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?. Turkish Journal of Obstetrics and Gynecology, vol.16, no.1, 2019, ss.35 - 40. 10.4274/tjod.galenos.2019.21384
AMA KALEM Z,ELLİBEŞ KAYA A,BAKIRARAR B,KALEM M Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?. Turkish Journal of Obstetrics and Gynecology. 2019; 16(1): 35 - 40. 10.4274/tjod.galenos.2019.21384
Vancouver KALEM Z,ELLİBEŞ KAYA A,BAKIRARAR B,KALEM M Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?. Turkish Journal of Obstetrics and Gynecology. 2019; 16(1): 35 - 40. 10.4274/tjod.galenos.2019.21384
IEEE KALEM Z,ELLİBEŞ KAYA A,BAKIRARAR B,KALEM M "Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?." Turkish Journal of Obstetrics and Gynecology, 16, ss.35 - 40, 2019. 10.4274/tjod.galenos.2019.21384
ISNAD KALEM, Ziya vd. "Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?". Turkish Journal of Obstetrics and Gynecology 16/1 (2019), 35-40. https://doi.org/10.4274/tjod.galenos.2019.21384
Sayfa Oluşturulma Tarihi
23-04-2024 13:48

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları